Penumbra Inc Revenue Growth Rates (PEN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Penumbra Inc  (NYSE: PEN)
 

PEN's Revenue Growth by Quarter and Year

Penumbra Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PEN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 390.05
1st Quarter March 374.76
FY 764.81

PENs Annual Revenue
Penumbra Inc's Revenue in the fiscal year 2025 $ 1,403.67 millions
Penumbra Inc's Revenue in the fiscal year 2024 $ 1,194.62 millions
Penumbra Inc's Revenue in the fiscal year 2023 $ 1,058.52 millions
Penumbra Inc's Revenue in the fiscal year 2022 $ 847.13 millions
Penumbra Inc's Revenue in the fiscal year 2021 $ 747.59 millions




PEN Revenue second quarter 2026 Y/Y Growth Comment
Penumbra Inc reported Revenue increase of 14.9% year on year in the second quarter 2026, to $ 390.05 millions, this is lower than Penumbra Inc's recent average Revenue improvement of 24.3%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 122 other companies have achieved higher Revenue growth. While Penumbra Inc' s Revenue growth of 14.9% ranks overall at the positon no. 2277 in the second quarter 2026.


PEN Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 22.14 % 10.83 % 28.69 %
3rd Quarter September - 17.82 % 11.11 % 26.8 %
2nd Quarter June 14.9 % 13.38 % 14.49 % 25.52 %
1st Quarter March 15.62 % 16.32 % 15.43 % 18.39 %
FY   - 17.5 % 12.86 % -

Financial Statements
Penumbra Inc's second quarter 2026 Revenue $ 390.05 millions PEN's Income Statement
Penumbra Inc's second quarter 2025 Revenue $ 339.46 millions Quarterly PEN's Income Statement


PEN Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 8.66 % 4.81 % 5.07 %
3rd Quarter September - 4.49 % 0.55 % 3.61 %
2nd Quarter June 4.08 % 4.73 % 7.44 % 8.33 %
1st Quarter March -2.76 % 2.73 % -2.11 % 9.12 %
FY (Year on Year)   - 17.5 % 12.86 % -


Back to PEN Growth rate Comparisons >> Back to PEN Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #123
Healthcare Sector #331
Overall #2277

Revenue Y/Y Growth Statistics
High Average Low
52.79 % 24.3 % 2.38 %
(Jun 30 2016)  
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #123
Healthcare Sector #331
Overall #2277
Revenue Y/Y Growth Statistics
High Average Low
52.79 % 24.3 % 2.38 %
(Jun 30 2016)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Penumbra Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
43.73 % 5.99 % -23.46 %
(Sep 30 2020)  


PEN's II. Quarter Q/Q Revenue Comment
Penumbra Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.08% quarter on quarter, to $ 390.05 millions.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Penumbra Inc's Revenue growth quarter on quarter, overall rank is 1237.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1237
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1237
Revenue Q/Q Growth Statistics
High Average Low
43.73 % 5.99 % -23.46 %
(Sep 30 2020)  


PEN's II. Quarter Q/Q Revenue Comment
Penumbra Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.08% quarter on quarter, to $ 390.05 millions.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Penumbra Inc's Revenue growth quarter on quarter, overall rank is 1237.


Penumbra Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1,504.87 $ 1,454.28 $ 1,403.67 $ 1,333.80 $ 1,280.15
Y / Y Revenue Growth (TTM) 17.55 % 17.27 % 17.5 % 14.61 % 12.92 %
Year on Year Revenue Growth Overall Ranking # 1247 # 983 # 699 # 279 # 320
Seqeuential Revenue Change (TTM) 3.48 % 3.61 % 5.24 % 4.19 % 3.23 %
Seq. Revenue Growth (TTM) Overall Ranking # 2277 # 1822 # 1510 # 902 # 1224


Cumulative Revenue growth Comment
Although Penumbra Inc's Annual Revenue growth year on year were below company's average 24.3% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 17.55% year on year, from 17.27% in Mar 31 2026.

In the Healthcare sector 221 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 983 to 1247.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 123
Healthcare Sector # 222
Overall # 1247

Revenue TTM Y/Y Growth Statistics
High Average Low
52.79 %
 24.3 %
2.38 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 123
Sector # 331
S&P 500 # 2277
Cumulative Revenue growth Comment
Although Penumbra Inc's Annual Revenue growth year on year were below company's average 24.3% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 17.55% year on year, from 17.27% in Mar 31 2026.

In the Healthcare sector 221 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 983 to 1247.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 123
Healthcare Sector # 222
Overall # 1247

Revenue TTM Y/Y Growth Statistics
High Average Low
52.79 %
24.3 %
2.38 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 123
Sector # 331
S&P 500 # 2277




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PEN's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Lifestance Health Group Inc 26.08%$ 26.076 millions
Ani Pharmaceuticals Inc25.87%$ 25.866 millions
Sight Sciences Inc 25.83%$ 25.830 millions
Grail Inc 25.72%$ 25.723 millions
Fortress Biotech Inc 25.66%$ 25.658 millions
Apyx Medical Corp25.27%$ 25.273 millions
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions
Axogen inc 23.06%$ 23.065 millions
Vericel Corporation22.48%$ 22.481 millions
Milestone Scientific Inc 22.28%$ 22.276 millions
Alpha Teknova Inc 22.05%$ 22.045 millions
X4 Pharmaceuticals Inc21.64%$ 21.642 millions
Exagen Inc 21.63%$ 21.629 millions
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions


About Penumbra Inc Revenue Growth Rates (PEN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Penumbra Inc (CIK 1321732).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001321732-26-000037
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Penumbra Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.